OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights
Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A. Ewes, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 12
Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A. Ewes, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 12
Showing 12 citing articles:
Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study
Noura F.M. El Hamaky, Abdelrahman Hamdi, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107437-107437
Closed Access | Times Cited: 10
Noura F.M. El Hamaky, Abdelrahman Hamdi, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107437-107437
Closed Access | Times Cited: 10
Unraveling the Nephroprotective Potential of Papaverine against Cisplatin Toxicity through Mitigating Oxidative Stress and Inflammation: Insights from In Silico, In Vitro, and In Vivo Investigations
Shimaa A. Abass, Abdullah A. Elgazar, Sanad S. El-Kholy, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 1927-1927
Open Access | Times Cited: 9
Shimaa A. Abass, Abdullah A. Elgazar, Sanad S. El-Kholy, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 1927-1927
Open Access | Times Cited: 9
Unveiling the Multitarget Potential of a Rare Caffeoyl Ester from Artemisia capillaris for Diabetes Mellitus: An Integrated In Vitro and In Silico Study
Md. Nurul Islam, Manh Tuan Ha, Byung Sun Min, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1286-1286
Open Access
Md. Nurul Islam, Manh Tuan Ha, Byung Sun Min, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1286-1286
Open Access
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study
Wafaa A. Ewes, Samar S. Tawfik, Aya M. Almatary, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3186-3186
Open Access | Times Cited: 5
Wafaa A. Ewes, Samar S. Tawfik, Aya M. Almatary, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3186-3186
Open Access | Times Cited: 5
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 4
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 4
Aldo-keto reductases: Role in cancer development and theranostics
Siddavaram Nagini, Prathap Reddy Kallamadi, Kranthi Kiran Kishore Tanagala, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 8, pp. 1287-1308
Open Access | Times Cited: 2
Siddavaram Nagini, Prathap Reddy Kallamadi, Kranthi Kiran Kishore Tanagala, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 8, pp. 1287-1308
Open Access | Times Cited: 2
In-silico Binding, Stability, Pharmacokinetics, and Toxicity Studies on Natural (-)-ambrox Metabolites as Binding Ligands to Luminal B and Triple-negative/basal-like Proteins for Breast Cancer Therapy
Abdullah Haikal, Neelaveni Thangavel, Mohammed Albratty, et al.
Letters in Drug Design & Discovery (2024) Vol. 21, Iss. 9, pp. 1569-1581
Closed Access | Times Cited: 1
Abdullah Haikal, Neelaveni Thangavel, Mohammed Albratty, et al.
Letters in Drug Design & Discovery (2024) Vol. 21, Iss. 9, pp. 1569-1581
Closed Access | Times Cited: 1
AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans
Israa M. Shamkh, Mahmoud Elkazzaz, Enas S. Radwan, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 34, pp. 2752-2762
Closed Access | Times Cited: 2
Israa M. Shamkh, Mahmoud Elkazzaz, Enas S. Radwan, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 34, pp. 2752-2762
Closed Access | Times Cited: 2
Development of non-acidic 4-methylbenzenesulfonate-based aldose reductase inhibitors; Design, Synthesis, biological evaluation and in-silico studies
Gehad E. Said, Heba M. Metwally, Ehab Abdel‐Latif, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107666-107666
Closed Access
Gehad E. Said, Heba M. Metwally, Ehab Abdel‐Latif, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107666-107666
Closed Access
Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements
Sneha Gupta, Sumeet Jha, Supriya Rani, et al.
ChemistryOpen (2024)
Open Access
Sneha Gupta, Sumeet Jha, Supriya Rani, et al.
ChemistryOpen (2024)
Open Access
Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents
Heba Adawy, Samar S. Tawfik, Abdullah A. Elgazar, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35239-35254
Open Access
Heba Adawy, Samar S. Tawfik, Abdullah A. Elgazar, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35239-35254
Open Access
Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors
Mohammad M. Al‐Sanea, Hani M. Hafez, Ahmed A. B. Mohamed, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5109-5127
Open Access
Mohammad M. Al‐Sanea, Hani M. Hafez, Ahmed A. B. Mohamed, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5109-5127
Open Access
Unveiling the potential anticancer activity of new dihydropyrimidines through dual inhibition of EGFR and TrkA: Design, synthesis, and in silico study
Aya M Slly, Wafaa A. Ewes, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107962-107962
Closed Access
Aya M Slly, Wafaa A. Ewes, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107962-107962
Closed Access
